Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Placebo-controlled Clinical Study Investigating Efficacy and Safety of Arbidol (Umifenovir) in Treatment and Prophylaxis of Influenza and Common Cold.

NCT01651663 is registered in ClinicalTrials.gov with Pharmstandard as lead sponsor.

NCT NCT01651663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01651663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Placebo-controlled Clinical Study Investigating Efficacy and Safety of Arbidol (Umifenovir) in Treatment and Prophylaxis of Influenza and Common Cold.
Lead sponsor
Pharmstandard
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
June 30, 2015
Enrollment
840 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza